樂觀
$10.23
情境價格
$4.495
-0.285 (-6.35%)收盤時
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.
Evolent Health Inc is a good buy right now due to its recent price performance and favorable technical indicators. The current price is $4.8, with a recent 5-day change of +5.03% and a 20-day change of +32.96%. The RSI is at 63.566, indicating bullish momentum. However, the main risk is the high net debt-to-EBITDA ratio of 7x, which could lead to capital raising under unfavorable conditions.
Citi
$6
2026-08-10
Citi
2026-08-10
目標價
$6
Canaccord
$6
2026-08-10
Canaccord
2026-08-10
目標價
$6
TD Cowen
$5
2026-07-28
TD Cowen
2026-07-28
目標價
$5
Citi
—
2026-07-23
Citi
2026-07-23
目標價
—
Canaccord
$7
2026-07-21
Canaccord
2026-07-21
目標價
$7
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Evolent Health to Release Q3 2026 Financial Results on November 5

Expanded Partnership Enhances Language Access Across Evolent's Network

Evolent Expands Partnership with TransPerfect to Enhance Language Access

Healthcare Stock Investment Opportunities and Risks Analysis

Evolent Health (EVH) Q2 2026 Earnings Call Transcript
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner. It operates in the Healthcare sector (SERVICES-MANAGEMENT SERVICES industry).
Evolent Health Inc is a good buy right now due to its recent price performance and favorable technical indicators. The current price is $4.8, with a recent 5-day change of +5.03% and a 20-day change of +32.96%. The RSI is at 63.566, indicating bullish momentum. However, the main risk is the high net debt-to-EBITDA ratio of 7x, which could lead to capital raising under unfavorable conditions.
13 analysts cover EVH: 13 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.33.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。